# A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

> clinical trial · VERIFIED · 2026-06-16

Status: RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Advanced/Metastatic Non-Small Cell Lung Cancer

- Company: Regeneron Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07154290

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.